Editor

Joel M. Topf, MD, FACP

Editor

Joel Topf, MD, FACP, serves on the Nephrology Times editorial board. A board certified clinical nephrologist in Detroit, he is a partner at St. Clair Nephrology and medical director of St. Clair Nephrology Research. He teaches nephrology fellows, residents, and medical students at St. John Hospital and Medical Center and is an assistant clinical professor at Oakland University William Beaumont School of Medicine.

Disclosures: Dr. Topf has an ownership stake in DaVita dialysis clinics and his practice runs a vascular access center. Since 2023, he has participated in advisory boards with Cara Therapeutics, CSL Vifor, AstraZeneca, Bayer, Renibus, Travere Therapeutics, Novo Nordisk, and GlaxoSmithKline.

Articles by Joel M. Topf, MD, FACP

Mini Michael, MDNKF Spring Clinical Meetings 2025 | May 2, 2025
Joel Topf spoke with Mini Michael about the ILLUMINATE-B study of lumasiran for PH1 in infants and young children.
Melanie Betz, MS, RD, CSR, FNKF, FANDNKF Spring Clinical Meetings 2025 | June 23, 2025
Joel Topf spoke with dietitian Melanie Betz about potassium, oxalate, and other renal nutrition concerns.
Areef Ishani, MDNKF Spring Clinical Meetings 2025 | April 30, 2025
Joel Topf spoke with Areef Ishani about kidney stone outcomes from the Diuretic Comparison Project, a study of US veterans.
Roger Rodby, MDNKF Spring Clinical Meetings 2025 | May 20, 2025
Joel Topf spoke to Seldin Award winner Roger Rodby at the National Kidney Foundation Spring Clinical Meetings 2025.
Kathleen Liu, MDNKF Spring Clinical Meetings 2025 | June 13, 2025
Joel Topf spoke with Kathleen Liu about acute kidney injury and other topics ahead of her Massry lecture at SCM25.
Bradley Warady, MDNKF Spring Clinical Meetings 2025 | April 25, 2025
We spoke to David M. Hume Award winner Bradley Warady, MD, at the National Kidney Foundation Spring Clinical Meetings 2025.
Meghan Sise, MDNKF Spring Clinical Meetings 2025 | July 7, 2025
Joel Topf spoke to onconephrologist Meghan Sise about her carboplatin dosing research at SCM25.
James Tumlin, MDNKF Spring Clinical Meetings 2025 | April 23, 2025
Joel Topf caught up with James Tumlin at NKF SCM25 to talk about Dr. Tumlin's late-breaking abstract on sparsentan in FSGS.
Jeffrey Perl, MDNKF Spring Clinical Meetings 2025 | April 22, 2025
Joel Topf spoke with Lazarus Award winner Jeffrey Perl at the National Kidney Foundation Spring Clinical Meetings 2025.
Connie Rhee, MDNKF Spring Clinical Meetings 2025 | April 21, 2025
Joel Topf spoke with Connie Rhee at SCM25 about her study on cognitive function with dialysis vs conservative CKD management.
Bradley Marder, MDNKF Spring Clinical Meetings 2025 | April 18, 2025
Joel Topf spoke with Bradley Marder of Amgen about gout studies at the NKF Spring Clinical Meetings 2025.
Jayme Locke, MD, MPHNKF Spring Clinical Meetings 2025 | April 17, 2025
Joel Topf spoke to Excellence in Transplantation Award winner Jayme Locke at the National Kidney Foundation SCM25.
Guru Reddy, PhDASN Kidney Week 2024 | June 23, 2025
Guru Reddy discussed three posters presented by Unicycive Therapeutics at ASN Kidney Week 2024, on UNI-494 and OLC.
Jonathan Barratt, PhDASN Kidney Week 2024 | June 23, 2025
Jonathan Barratt discussed advances in IgA nephropathy treatment with Joel Topf at ASN Kidney Week 2024.
Melissa Little, PhDASN Kidney Week 2024 | June 13, 2025
Melissa Little discussed kidney regeneration and her stem cell research with Joel Topf of Nephrology Times.
Mohamad A. Hussain, MD, PhDASN Kidney Week 2024 | June 23, 2025
Mohamad Hussain spoke with us about a phase 3 trial of the acellular tissue engineered vessel in AV access for hemodialysis.
Roger Rodby, MDASN Kidney Week 2024 | June 13, 2025
After their poster tour at ASN Kidney Week 2024, Roger Rodby and Edgar Lerma shared a few highlights with Joel Topf.
Katherine Tuttle, MDASN Kidney Week 2024 | June 23, 2025
Katherine Tuttle spoke with Joel Topf about FLOW trial results presented at ASN Kidney Week 2024.
Hiddo Heerspink, PhDASN Kidney Week 2024 | June 23, 2025
Hiddo Heerspink discussed his Kidney Week presentations on SC0062 for IgAN and semaglutide in obesity with nondiabetic CKD.
Jonathan Barratt, PhDASN Kidney Week 2024 | June 23, 2025
Jonathan Barratt discussed his research on the anti-APRIL antibody sibeprenlimab in the treatment of IgA nephropathy.